Robertson IG - Search Results

1

Inhibition by SKF-525A of the aldehyde oxidase-mediated metabolism of the experimental antitumour agent acridine carboxamide.

Robertson IG, Bland TJ. Robertson IG, et al. Biochem Pharmacol. 1993 May 25;45(10):2159-62. doi: 10.1016/0006-2952(93)90031-q. Biochem Pharmacol. 1993. PMID: 8512597

2

Thiolytic cleavage and binding of the antitumour agent CI-921 in blood.

Kestell P, Paxton JW, Robertson IG, Evans PC, Dormer RA, Baguley BC. Kestell P, et al. Among authors: robertson ig. Drug Metabol Drug Interact. 1988;6(3-4):327-36. doi: 10.1515/dmdi.1988.6.3-4.327. Drug Metabol Drug Interact. 1988. PMID: 3271644

3

Rat hepatocyte-mediated metabolism of the experimental anti-tumour agent N-[2'-(dimethylamino)ethyl]acridine-4-carboxamide.

Schlemper B, Siegers DJ, Paxton JW, Robertson IG. Schlemper B, et al. Among authors: robertson ig. Xenobiotica. 1993 Apr;23(4):361-71. doi: 10.3109/00498259309057024. Xenobiotica. 1993. PMID: 8337894

4

Tumour profile of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide after intraperitoneal administration in the mouse.

Paxton JW, Young D, Evans SM, Robertson IG, Kestell P. Paxton JW, et al. Among authors: robertson ig. Cancer Chemother Pharmacol. 1993;32(4):320-2. doi: 10.1007/BF00686179. Cancer Chemother Pharmacol. 1993. PMID: 8324875

5

Methadone: a potent inhibitor of rat liver aldehyde oxidase.

Robertson IG, Gamage RS. Robertson IG, et al. Biochem Pharmacol. 1994 Feb 9;47(3):584-7. doi: 10.1016/0006-2952(94)90192-9. Biochem Pharmacol. 1994. PMID: 8117328

6

Metabolism of the experimental antitumor agent acridine carboxamide in the mouse.

Robertson IG, Palmer BD, Paxton JW, Bland TJ. Robertson IG, et al. Drug Metab Dispos. 1993 May-Jun;21(3):530-6. Drug Metab Dispos. 1993. PMID: 8100511

7

Intraperitoneal administration of the antitumour agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in the mouse: bioavailability, pharmacokinetics and toxicity after a single dose.

Evans SM, Young D, Robertson IG, Paxton JW. Evans SM, et al. Among authors: robertson ig. Cancer Chemother Pharmacol. 1992;31(1):32-6. doi: 10.1007/BF00695991. Cancer Chemother Pharmacol. 1992. PMID: 1458557

8

Pharmacokinetics and toxicity of the antitumour agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide after i.v. administration in the mouse.

Paxton JW, Young D, Evans SM, Kestell P, Robertson IG, Cornford EM. Paxton JW, et al. Among authors: robertson ig. Cancer Chemother Pharmacol. 1992;29(5):379-84. doi: 10.1007/BF00686007. Cancer Chemother Pharmacol. 1992. PMID: 1551177

9

The characterization of two biliary glutathione conjugates of amsacrine using liquid secondary ion mass spectrometry.

Robertson IG, Palmer BD, Shaw GJ. Robertson IG, et al. Biol Mass Spectrom. 1993 Nov;22(11):661-5. doi: 10.1002/bms.1200221107. Biol Mass Spectrom. 1993. PMID: 8251552

10

Inter-species variation in the metabolism and inhibition of N-[(2'-dimethylamino)ethyl]acridine-4-carboxamide (DACA) by aldehyde oxidase.

Schofield PC, Robertson IG, Paxton JW. Schofield PC, et al. Among authors: robertson ig. Biochem Pharmacol. 2000 Jan 15;59(2):161-5. doi: 10.1016/s0006-2952(99)00323-8. Biochem Pharmacol. 2000. PMID: 10810450

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results